Please login to the form below

Not currently logged in
Email:
Password:

Matt Regan named AbbVie’s general manager in UK

Was formerly general manager of Abbott in Norway

Matt Regan, AbbVieAbbVie, the new independent biopharma spin-out from Abbott, has appointed Matt Regan as general manager of its UK business.

Regan was formerly general manager for Abbott in Norway and will now oversee the new firm's UK presence as it establishes itself as a separate research-based pharma company.

During his time in Norway, Regan set up and led the Norwegian Industry Association's Biosimilars committee, and helped establish Abbott as one of the fastest growing pharma companies in the region.

He has been with Abbott for more than a decade, serving in several European roles, including as regional director, North Europe for Abbott Diabetes Care, and general manager of the Baltic States for Abbott.

4th January 2013

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics